title: Guidance to Achieve Accurate Aggregate Quantitation in Biopharmaceuticals by SV-AUC.
abstract: The levels and types of aggregates present in protein biopharmaceuticals must be assessed during all stages of product development, manufacturing, and storage of the finished product. Routine monitoring of aggregate levels in biopharmaceuticals is typically achieved by size exclusion chromatography (SEC) due to its high precision, speed, robustness, and simplicity to operate. However, SEC is error prone and requires careful method development to ensure accuracy of reported aggregate levels. Sedimentation velocity analytical ultracentrifugation (SV-AUC) is an orthogonal technique that can be used to measure protein aggregation without many of the potential inaccuracies of SEC. In this chapter, we discuss applications of SV-AUC during biopharmaceutical development and how characteristics of the technique make it better suited for some applications than others. We then discuss the elements of a comprehensive analytical control strategy for SV-AUC. Successful implementation of these analytical control elements ensures that SV-AUC provides continued value over the long time frames necessary to bring biopharmaceuticals to market.
authors.affiliation: Attribute Sciences, Amgen Inc., Longmont, Colorado, USA.
authors.forename: Kelly K
authors.initials: KK
authors.lastname: Arthur
authors.affiliation: Attribute Sciences, Amgen Inc., Longmont, Colorado, USA.
authors.forename: Brent S
authors.initials: BS
authors.lastname: Kendrick
authors.affiliation: Attribute Sciences, Amgen Inc., Longmont, Colorado, USA. Electronic address: jgabriel@elionlabs.com.
authors.forename: John P
authors.initials: JP
authors.lastname: Gabrielson
mesh_terms: D001702:Biopharmaceutics; D006801:Humans; D008970:Molecular Weight; D066329:Protein Aggregates; D011506:Proteins / Q000737:chemistry / Q000302:isolation & purification*; D014461:Ultracentrifugation / Q000379:methods
chemical_list: D066329:Protein Aggregates; D011506:Proteins
keywords: Analytical ultracentrifugation; Biopharmaceuticals; Protein aggregation; Sedimentation velocity; Therapeutic proteins